Registry for patients needing massive blood transfusions in Australia and New Zealand

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Australian and New Zealand Massive Transfusion Registry (ANZ-MTR) collects and analyzes data from patients who have experienced significant blood loss requiring massive transfusions across various clinical settings, including trauma and surgery. By utilizing electronic data extraction and linkage methodologies, the registry compiles information from multiple hospital sources to improve understanding of transfusion practices and patient outcomes. With over 6,000 patients already included, the ANZ-MTR aims to transition into a sustainable operational model that aligns with national safety and quality frameworks while facilitating ongoing research opportunities.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* aged 18 years or over
* 5 or more units of red blood cells in any 4 hour period

Exclusion Criteria:

* nil

Where it's running

• Monash University
  Melbourne, Victoria, Australia Recruiting

Study contacts

• Principal investigator: Erica Wood, MBBS — Monash University
• Study coordinator: Erica Wood, MBBS
• Email: sphpm.mtr@monash.edu
• Phone: 1800 811 326

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Endovascular treatment outcomes after portal hypertension–related GI bleeding in cirrhosis

  This study tests how well endovascular procedures for portal hypertension–related GI bleeding work in adults with cirrhosis, and what factors predict outcomes.

  Recruiting University Medical Center Ho Chi Minh City (UMC) · Ho Chi Minh City · NCT07918378

• Expanding HIV-positive donor livers for HIV-positive recipients

  This study tests whether liver transplants from HIV-positive donors to HIV-positive recipients are safe regarding opportunistic infections and cancer.

  Recruiting at 2 sites National Institute of Allergy and Infectious Diseases (NIAID) · Baltimore, Maryland and 1 other locations · NCT07778459

• Magnetic Resonance Cholangiopancreatography to help living liver donors and their recipients

  This study tests whether preoperative MRCP imaging can help select living liver donors and reduce biliary complications in recipients.

  Recruiting Institute of Liver and Biliary Sciences, India · New Delhi · NCT07715500

• Appropriateness of Hemostatic Agent Use in Cardiovascular Surgery

  This study tests how well surgeons’ choices about topical hemostatic agents match current guidelines in cardiac and vascular surgery at one Milan hospital.

  Recruiting University of Milan · Milan, MI · NCT07699016

• Tegoprazan to prevent GI complications in ischemic stroke patients on antiplatelet therapy

  This trial tests whether tegoprazan can lower gastrointestinal complications in adults with ischemic stroke or TIA who are starting antiplatelet therapy.

  Recruiting at 24 sites Phase 3 Hanyang University · Busan, Busan and 23 other locations · NCT07687706

• Reducing Immunosuppression by 50% in Young Liver Transplant Recipients

  This study tests whether cutting the immunosuppressive medicine by half in children with liver transplants is safe and effective.

  Recruiting at 7 sites Phase 2 National Institute of Allergy and Infectious Diseases (NIAID) · San Francisco, California and 10 other locations · NCT07549503

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.